GH secretagogue

Ipamorelin

Limited human data

Selective ghrelin receptor (GHS-R1a) agonist that triggers a growth hormone pulse with little effect on cortisol or prolactin, which is the main reason it is chosen over hexarelin or GHRP-6.

SubQBeginnerNot approved anywhererecovery and sleepmuscle growthinjury repairfat loss

Also known as NNC 26-0161

At a glance

Dose summary

Typical dose200 mcg
Range100 mcg–300 mcg
FrequencyDaily
Half-life~2 h
ScheduleOnce daily
Cycle length12 weeks
RouteSubQ
Experience levelBeginner
Evidence gradeLimited human data
ApprovalNot approved anywhere
Where the dose comes fromCommunity practice, not a trial

No regulator and no trial set these numbers. They describe what people actually do, recorded so you can see the range rather than guess at it — which is not the same thing as a recommendation.

Reconstitution

What to draw, at the usual vial

A 5 mg vial reconstituted with 2 mL of bacteriostatic water gives 2.50 mg/mL. A typical 200 mcg dose is 0.080 mL — pull the plunger to 8 units on a U-100 syringe.

Concentration2.50 mg/mL
Draw volume0.080 mL
U-100 units8 units
Doses per vial25

Same dose, other vial sizes

VialWaterConcentrationDrawUnitsDoses
5 mg2 mL2.50 mg/mL0.080 mL8 units25
10 mg2 mL5.00 mg/mL0.040 mL4 units50

The highlighted row is the one quoted above: the smallest listed vial that holds at least four typical doses. Change any of it — a different vial, more or less water, a different dose — on the reconstitution calculator, which draws the syringe to true U-100 graduations.

Mechanism & evidence

What it is, and what is known

Selective ghrelin receptor (GHS-R1a) agonist that triggers a growth hormone pulse with little effect on cortisol or prolactin, which is the main reason it is chosen over hexarelin or GHRP-6. Published human work is limited to small early-phase and post-operative ileus studies; development was discontinued and it is NOT an approved medicine anywhere. Everything sold to consumers is research-chemical grade, so the community 100-300 mcg per dose range comes from practice rather than from a label.

The caveat

Small early-phase and post-operative ileus studies; development was discontinued.

Tolerability

Reported side effects

  • Injection site redness or itching
  • Head rush or flushing shortly after injection
  • Water retention and morning puffiness
  • Tingling or numbness in the hands, which can reflect carpal tunnel pressure
  • Vivid dreams or grogginess when dosed pre-bed

Hard stops

Do not use this if

  • Pregnancy, possible pregnancy, or breastfeeding
  • Active, suspected or recently treated malignancy
  • Under 18

These are flags, not a screening. They do not replace a conversation with a clinician who knows your history.

Handling

Storage

Sealed powder, refrigerated24 months
After reconstitution, refrigerated30 days

Keep it cold, keep it dark, and label the vial with the date you mixed it. Discard anything cloudy or past the window above.

Combinations

Commonly stacked with

Stacking multiplies the side-effect surface and makes it impossible to tell which compound did what. Add one thing at a time.

Where it shows up

Protocols using this compound

References

Sources

Educational information only, not medical advice. Talk to a licensed clinician before starting, changing, or stopping anything.